A new international pricing analysis underscores that the United States remains the most expensive country in the world for brand-name prescription drugs.
A new international pricing analysis underscores that the United States remains the most expensive country in the world for brand-name prescription drugs.
Johnson & Johnson agrees to cut U.S. drug prices, gain Trump tariff exemptions, expand Medicaid access, and boost domestic manufacturing.
The American Bazaar is a publication of American Bazaar, Inc., based in Germantown, MD.
